The development of acute respiratory distress syndrome (ARDS) is known to be independently attributable to aspiration-induced lung injury. Mechanical ventilation as a high pressure/volume support to maintain sufficient oxygenation of a patient could initiate ventilator-induced lung injury (VILI) and thus contribute to lung damage. Although these phenomena are rare in the clinic, they could serve as the severe experimental model of alveolar-capillary membrane deterioration. Lung collapse, diffuse inflammation, alveolar epithelial and endothelial damage, leakage of fluid into the alveoli, and subsequent inactivation of pulmonary surfactant, leading to respiratory failure. Therefore, exogenous surfactant could be considered as a therapy to restore lung function in experimental ARDS. This study aimed to investigate the effect of modified porcine surfactant in animal model of severe ARDS (P/F ratio

Department of Physiology Jessenius Faculty of Medicine in Martin Comenius University in Bratislava Martin Slovak Republic

See more in PubMed

Marik PE. Aspiration pneumonitis and aspiration pneumonia. N Engl J Med. 2001;344:665–671. doi: 10.1056/NEJM200103013440908. PubMed DOI

Raghavendran K, Nemzek J, Napolitano LM, Knight PR. Aspiration-induced lung injury. Crit Care Med. 2011;39:818–826. doi: 10.1097/CCM.0b013e31820a856b. PubMed DOI PMC

Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med. 2000;342:1334–1349. doi: 10.1056/NEJM200005043421806. PubMed DOI

Slutsky AS, Ranieri VM. Ventilator-induced lung injury. N Engl J Med. 2013;369:2126–2136. doi: 10.1056/NEJMra1208707. PubMed DOI

Hoegl S, Burns N, Angulo M, Francis D, Osborne CM, Mills TW, Blackburn, et al. Capturing the multifactorial nature of ARDS - “Two-hit” approach to model murine acute lung injury. Physiol Rep. 2018;6:e13648. doi: 10.14814/phy2.136486. PubMed DOI PMC

Verbrugge SJ, Sorm V, Lachmann B. Mechanisms of acute respiratory distress syndrome: role of surfactant changes and mechanical ventilation. J Physiol Pharmacol. 1997;48:537–557. PubMed

Pierrakos C, Karanikolas M, Scolletta S, Karamouzos V, Velissaris D. Acute respiratory distress syndrome: pathophysiology and therapeutic options. J Clin Med Res. 2012;4:7–16. doi: 10.4021/jocmr761w. PubMed DOI PMC

Eijking EP, Gommers D, So KL, Vergeer M, Lachmann B. Surfactant treatment of respiratory failure induced by hydrochloric acid aspiration in rats. Anesthesiology. 1993;78:1145–1151. doi: 10.1097/00000542-199306000-00019. PubMed DOI

Matthay MA, Zemans RL, Zimmerman GA, Arabi YM, Beitler JR, Mercat A, Herridge M, et al. Acute respiratory distress syndrome. Nat Rev Dis Primers. 2019;5:18. doi: 10.1038/s41572-019-0069-0. PubMed DOI PMC

Calkovska A, Mokra D, Calkovsky V, Matasova K, Zibolen M. Clinical considerations when treating neonatal aspiration syndromes. Expert Rev Respir Med. 2019;13:193–203. doi: 10.1080/17476348.2019.1562340. PubMed DOI

Dushianthan A, Cusack R, Goss V, Postle AD, Grocott MP. Clinical review: Exogenous surfactant therapy for acute lung injury/acute respiratory distress syndrome--where do we go from here? Crit Care. 2012;16:238. doi: 10.1186/cc11512. PubMed DOI PMC

Meng H, Sun Y, Lu J, Fu S, Meng Z, Scott M, Li Q. Exogenous surfactant may improve oxygenation but not mortality in adult patients with acute lung injury/acute respiratory distress syndrome: a meta-analysis of 9 clinical trials. J Cardiothorac Vasc Anesth. 2012;26:849–856. doi: 10.1053/j.jvca.2011.11.006. PubMed DOI PMC

Sanchez Luna M, Bacher P, Unnebrink K, Martinez-Tristani M, Ramos Navarro C. Beractant and poractant alfa in premature neonates with respiratory distress syndrome: a systematic review of real-world evidence studies and randomized controlled trials. J Perinatol. 2020;40:1121–1134. doi: 10.1038/s41372-020-0603-7. PubMed DOI PMC

Zebialowicz Ahlstrom J, Massaro F, Mikolka P, Feinstein R, Perchiazzi G, Basabe-Burgos O, Curstedt T, et al. Synthetic surfactant with a recombinant surfactant protein C analogue improves lung function and attenuates inflammation in a model of acute respiratory distress syndrome in adult rabbits. Respir Res. 2019;20:245. doi: 10.1186/s12931-019-1220-x. PubMed DOI PMC

Mikolka P, Curstedt T, Feinstein R, Larsson A, Grendar M, Rising A, Johansson J. Impact of synthetic surfactant CHF5633 with SP-B and SP-C analogues on lung function and inflammation in rabbit model of acute respiratory distress syndrome. Physiol Rep. 2021;9:e14700. doi: 10.14814/phy2.14700. PubMed DOI PMC

Meng SS, Chang W, Lu ZH, Xie JF, Qiu HB, Yang Y, Guo F-M. Effect of surfactant administration on outcomes of adult patients in acute respiratory distress syndrome: a meta-analysis of randomized controlled trials. BMC Pulm Med. 2019;19:9. doi: 10.1186/s12890-018-0761-y. PubMed DOI PMC

Zhang LN, Sun JP, Xue XY, Wang JX. Exogenous pulmonary surfactant for acute respiratory distress syndrome in adults: A systematic review and meta-analysis. Exp Ther Med. 2013;5:237–242. doi: 10.3892/etm.2012.746. PubMed DOI PMC

Piva S, DiBlasi RM, Slee AE, Jobe AH, Roccaro AM, Filippini M, Latronico N, et al. Surfactant therapy for COVID-19 related ARDS: a retrospective case-control pilot study. Respir Res. 2021;22:20. doi: 10.1186/s12931-020-01603-w. PubMed DOI PMC

Mikolka P, Kosutova P, Balentova S, Cierny D, Kopincova J, Kolomaznik M, Adamkov M, Calkovska A, Mokra D. Early cardiac injury in acute respiratory distress syndrome: comparison of two experimental models. Physiol Res. 2020;69(Suppl 3):S421–S432. doi: 10.33549/physiolres.934591. PubMed DOI PMC

Kosutova P, Mikolka P, Balentova S, Adamkov M, Calkovska A, Mokra D. Effects of PDE3 inhibitor olprinone on the respiratory parameters, inflammation, and apoptosis in an experimental model of acute respiratory distress syndrome. Int J Mol Sci. 2020;21:3382. doi: 10.3390/ijms21093382. PubMed DOI PMC

Mikolka P, Kosutova P, Kolomaznik M, Topercerova J, Kopincova J, Calkovska A, Mokra D. Effect of different dosages of dexamethasone therapy on lung function and inflammation in an early phase of acute respiratory distress syndrome model. Physiol Res. 2019;68(Suppl 3):S253–S263. doi: 10.33549/physiolres.934364. PubMed DOI

Force ADT, Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, et al. Acute respiratory distress syndrome: the Berlin definition. JAMA. 2012;307:2526–2533. doi: 10.1001/jama.2012.5669. PubMed DOI

Krolak-Olejnik B, Hozejowski R, Szczapa T. Dose Effect of Poractant Alfa in Neonatal RDS: Analysis of Combined Data from Three Prospective Studies. Front Pediatr. 2020;8:603716. doi: 10.3389/fped.2020.603716. PubMed DOI PMC

Matute-Bello G, Downey G, Moore BB, Groshong SD, Matthay MA, Slutsky AS, Kuebler WM Acute Lung Injury in Animals Study Group. An official American Thoracic Society workshop report: features and measurements of experimental acute lung injury in animals. Am J Respir Cell Mol Biol. 2011;44:725–738. doi: 10.1165/rcmb.2009-0210ST. PubMed DOI PMC

Bellani G, Laffey JG, Pham T, Fan E, Brochard L, Esteban A, Gattinoni L. Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA. 2016;315:788–800. doi: 10.1001/jama.2016.0291. PubMed DOI

Matute-Bello G, Frevert CW, Martin TR. Animal models of acute lung injury. Am J Physiol Lung Cell Mol Physiol. 2008;295:L379–L399. doi: 10.1152/ajplung.00010.2008. PubMed DOI PMC

Kennedy TP, Johnson KJ, Kunkel RG, Ward PA, Knight PR, Finch JS. Acute acid aspiration lung injury in the rat: biphasic pathogenesis. Anesth Analg. 1989;69:87–92. doi: 10.1213/00000539-198907000-00017. PubMed DOI

Hunt EB, Sullivan A, Galvin J, MacSharry J, Murphy DM. Gastric aspiration and its role in airway inflammation. Open Respir Med J. 2018;12:1–10. doi: 10.2174/1874306401812010001. PubMed DOI PMC

Maniatis NA, Sfika A, Nikitopoulou I, Vassiliou AG, Magkou C, Armaganidis A, et al. Acid-induced acute lung injury in mice is associated with P44/42 and c-Jun N-terminal kinase activation and requires the function of tumor necrosis factor alpha receptor I. Shock. 2012;38:381–386. doi: 10.1097/SHK.0b013e3182690ea2. PubMed DOI

Zimmermann AM, Roberts KD, Lampland AL, Meyers PA, Worwa CT, Plumm B, Pacheco MC, et al. Improved gas exchange and survival after KL-4 surfactant in newborn pigs with severe acute lung injury. Pediatr Pulmonol. 2010;45:782–788. doi: 10.1002/ppul.21252. PubMed DOI

Kallet RH. Mechanical ventilation in ARDS: quo vadis? Respir Care. 2022;67:730–749. doi: 10.4187/respcare.09832. PubMed DOI

Hernandez LA, Peevy KJ, Moise AA, Parker JC. Chest wall restriction limits high airway pressure-induced lung injury in young rabbits. J Appl Physiol (1985) 1989;66:2364–2368. doi: 10.1152/jappl.1989.66.5.2364. PubMed DOI

Carlton DP, Cummings JJ, Scheerer RG, Poulain FR, Bland RD. Lung overexpansion increases pulmonary microvascular protein permeability in young lambs. J Appl Physiol (1985) 1990;69:577–583. doi: 10.1152/jappl.1990.69.2.577. PubMed DOI

Adkins WK, Hernandez LA, Coker PJ, Buchanan B, Parker JC. Age effects susceptibility to pulmonary barotrauma in rabbits. Crit Care Med. 1991;19:390–393. doi: 10.1097/00003246-199103000-00018. PubMed DOI

Kamiyama J, Jesmin S, Sakuramoto H, Shimojyo N, Islam M, Hagiya K, Sugano M, et al. Hyperinflation deteriorates arterial oxygenation and lung injury in a rabbit model of ARDS with repeated open endotracheal suctioning. BMC Anesthesiol. 2015;15:73. doi: 10.1186/s12871-015-0045-5. PubMed DOI PMC

Ricci F, Salomone F, Kuypers E, Ophelders D, Nikiforou M, Willems M, Krieger T, et al. In vivo evaluation of the acute pulmonary response to poractant alfa and bovactant treatments in lung-lavaged adult rabbits and in preterm lambs with respiratory distress syndrome. Front Pediatr. 2017;5:186. doi: 10.3389/fped.2017.00186. PubMed DOI PMC

Zhu GF, Sun B, Niu SF, Cai YY, Lin K, Lindwall R, Robertson B. Combined surfactant therapy and inhaled nitric oxide in rabbits with oleic acid-induced acute respiratory distress syndrome. Am J Respir Crit Care Med. 1998;158:437–443. doi: 10.1164/ajrccm.158.2.9711107. PubMed DOI

Aspros AJ, Coto CG, Lewis JF, Veldhuizen RA. High-frequency oscillation and surfactant treatment in an acid aspiration model. Can J Physiol Pharmacol. 2010;88:14–20. doi: 10.1139/Y09-096. PubMed DOI

Williams AE, Chambers RC. The mercurial nature of neutrophils: still an enigma in ARDS? Am J Physiol Lung Cell Mol Physiol. 2014;306:L217–L230. doi: 10.1152/ajplung.00311.2013. PubMed DOI PMC

Donnelly SC, Strieter RM, Kunkel SL, Walz A, Robertson CR, Carter DC, Grant IS, et al. Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups. Lancet. 1993;341:643–647. doi: 10.1016/0140-6736(93)90416-E. PubMed DOI

Kalk P, Senf P, Deja M, Petersen B, Busch T, Bauer C, Boemke W, et al. Inhalation of an endothelin receptor A antagonist attenuates pulmonary inflammation in experimental acute lung injury. Can J Physiol Pharmacol. 2008;86:511–515. doi: 10.1139/Y08-046. PubMed DOI

Matthay MA, Zemans RL. The acute respiratory distress syndrome: pathogenesis and treatment. Annu Rev Pathol. 2011;6:147–163. doi: 10.1146/annurev-pathol-011110-130158. PubMed DOI PMC

Chimenti L, Morales-Quinteros L, Puig F, Camprubi-Rimblas M, Guillamat-Prats R, Gomez MN, Tijero J, et al. Comparison of direct and indirect models of early induced acute lung injury. Intensive Care Med Exp. 2020;8(Suppl 1):62. doi: 10.1186/s40635-020-00350-y. PubMed DOI PMC

Meduri GU, Annane D, Chrousos GP, Marik PE, Sinclair SE. Activation and regulation of systemic inflammation in ARDS: rationale for prolonged glucocorticoid therapy. Chest. 2009;136:1631–1643. doi: 10.1378/chest.08-2408. PubMed DOI

Pedrazza L, Cunha AA, Luft C, Nunes NK, Schimitz F, Gassen RB, Breda RV, et al. Mesenchymal stem cells improves survival in LPS-induced acute lung injury acting through inhibition of NETs formation. J Cell Physiol. 2017;232:3552–3564. doi: 10.1002/jcp.25816. PubMed DOI

Bersani I, Kunzmann S, Speer CP. Immunomodulatory properties of surfactant preparations. Expert Rev Anti Infect Ther. 2013;11:99–110. doi: 10.1586/eri.12.156. PubMed DOI

Lan CC, Wu YK, Peng CK, Huang KL, Wu CP. Surfactant attenuates air embolism-induced lung injury by suppressing NKCC1 expression and NF-kappaB Activation. Inflammation. 2021;44:57–67. doi: 10.1007/s10753-020-01266-1. PubMed DOI PMC

Ikegami M, Whitsett JA, Martis PC, Weaver TE. Reversibility of lung inflammation caused by SP-B deficiency. Am J Physiol Lung Cell Mol Physiol. 2005;289:L962–L970. doi: 10.1152/ajplung.00214.2005. PubMed DOI

Albertine KH, Soulier MF, Wang Z, Ishizaka A, Hashimoto S, Zimmerman GA, Matthay MA, Ware LB. Fas and fas ligand are up-regulated in pulmonary edema fluid and lung tissue of patients with acute lung injury and the acute respiratory distress syndrome. Am J Pathol. 2002;161:1783–1796. doi: 10.1016/S0002-9440(10)64455-0. PubMed DOI PMC

Gallelli L, Zhang L, Wang T, Fu F. Severe acute lung injury related to COVID-19 infection: a review and the possible role for escin. J Clin Pharmacol. 2020;60:815–825. doi: 10.1002/jcph.1644. PubMed DOI PMC

Grimbert FA, Parker JC, Taylor AE. Increased pulmonary vascular permeability following acid aspiration. J Appl Physiol Respir Environ Exerc Physiol. 1981;51:335–345. doi: 10.1152/jappl.1981.51.2.335. PubMed DOI

Kobayashi K, Horikami D, Omori K, Nakamura T, Yamazaki A, Maeda S, Murata T. Thromboxane A2 exacerbates acute lung injury via promoting edema formation. Sci Rep. 2016;6:32109. doi: 10.1038/srep32109. PubMed DOI PMC

Calkovska A, Uhliarova B, Joskova M, Franova S, Kolomaznik M, Calkovsky V, Smolarova S. Pulmonary surfactant in the airway physiology: a direct relaxing effect on the smooth muscle. Respir Physiol Neurobiol. 2015;209:95–105. doi: 10.1016/j.resp.2015.01.004. PubMed DOI

Aman J, van der Heijden M, van Lingen A, Girbes AR, van Nieuw Amerongen GP, van Hinsbergh VW, Johan Groeneveld AB. Plasma protein levels are markers of pulmonary vascular permeability and degree of lung injury in critically ill patients with or at risk for acute lung injury/acute respiratory distress syndrome. Crit Care Med. 2011;39:89–97. doi: 10.1097/CCM.0b013e3181feb46a. PubMed DOI

Calfee CS, Janz DR, Bernard GR, May AK, Kangelaris KN, Matthay MA, Hardie W, et al. Distinct molecular phenotypes of direct vs indirect ARDS in single-center and multicenter studies. Chest. 2015;147:1539–1548. doi: 10.1378/chest.14-2454. PubMed DOI PMC

Leikauf GD, McDowell SA, Bachurski CJ, Aronow BJ, Gammon K, Wesselkamper SC, Hardie W, et al. Functional genomics of oxidant-induced lung injury. Adv Exp Med Biol. 2001;500:479–487. doi: 10.1007/978-1-4615-0667-6_73. PubMed DOI

De Luca D, Autilio C. Strategies to protect surfactant and enhance its activity. Biomed J. 2021;44:654–662. doi: 10.1016/j.bj.2021.07.011. PubMed DOI PMC

Touqui L, Arbibe L. A role for phospholipase A2 in ARDS pathogenesis. Mol Med Today. 1999;5:244–249. doi: 10.1016/S1357-4310(99)01470-7. PubMed DOI

Raghavendran K, Willson D, Notter RH. Surfactant therapy for acute lung injury and acute respiratory distress syndrome. Crit Care Clin. 2011;27:525–559. doi: 10.1016/j.ccc.2011.04.005. PubMed DOI PMC

Robertson B. Surfactant inactivation and surfactant replacement in experimental models of ARDS. Acta Anaesthesiol Scand Suppl. 1991;95:22–28. doi: 10.1111/j.1399-6576.1991.tb03396.x. PubMed DOI

Sun B, Curstedt T, Robertson B. Surfactant inhibition in experimental meconium aspiration. Acta Paediatr. 1993;82:182–189. doi: 10.1111/j.1651-2227.1993.tb12635.x. PubMed DOI

Willson DF, Thomas NJ, Markovitz BP, Bauman LA, DiCarlo JV, Pon S, Jacobs BR, et al. Effect of exogenous surfactant (calfactant) in pediatric acute lung injury: a randomized controlled trial. JAMA. 2005;293:470–476. doi: 10.1001/jama.293.4.470. PubMed DOI

Spragg RG, Lewis JF, Wurst W, Hafner D, Baughman RP, Wewers MD, Marsh JJ. Treatment of acute respiratory distress syndrome with recombinant surfactant protein C surfactant. Am J Respir Crit Care Med. 2003;167:1562–1566. doi: 10.1164/rccm.200207-782OC. PubMed DOI

Willson DF, Notter RH. The future of exogenous surfactant therapy. Respir Care. 2011;56:1369–1386. doi: 10.4187/respcare.01306. discussion 86–88. PubMed DOI

The effect of budesonide delivered by high-frequency oscillatory ventilation on acute inflammatory response in severe lung injury in adult rabbits